Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 8

1.

Mutation Screening of BRCA Genes in 10 Iranian Males with Breast Cancer.

Zorrieh Zahra A, Kadkhoda S, Behjati F, Aghakhani Moghaddam F, Badiei A, Sirati F, Afshin Alavi H, Atri M, Omranipour R, Keyhani E.

Int J Mol Cell Med. 2016 Spring;5(2):114-22. Epub 2016 May 9.

2.

The Genotoxic and Cytotoxic Effects of Bisphenol-A (BPA) in MCF-7 Cell Line and Amniocytes.

Aghajanpour-Mir SM, Zabihi E, Akhavan-Niaki H, Keyhani E, Bagherizadeh I, Biglari S, Behjati F.

Int J Mol Cell Med. 2016 Winter;5(1):19-29.

3.

Liquid base cytology in evaluation of thyroid nodules.

Keyhani E, Sharghi SA, Amini R, Sharghi SA, Karimlou M, Moghaddam FA, Larijani B.

J Diabetes Metab Disord. 2014 Sep 10;13(1):82. doi: 10.1186/s40200-014-0082-5. eCollection 2014.

4.

Angiogenesis markers in breast cancer--potentially useful tools for priority setting of anti-angiogenic agents.

Keyhani E, Muhammadnejad A, Behjati F, Sirati F, Khodadadi F, Karimlou M, Moghaddam FA, Pazhoomand R.

Asian Pac J Cancer Prev. 2013;14(12):7651-6.

5.

Detection of HER2 status in breast cancer: comparison of current methods with MLPA and real-time RT-PCR.

Pazhoomand R, Keyhani E, Banan M, Najmabadi H, Khodadadi F, Iraniparast A, Feiz F, Majidzadeh K, Bahman I, Moghadam FA, Sobhani AM, Muhammadnejad A, Abedini SS, Behjati F.

Asian Pac J Cancer Prev. 2013;14(12):7621-8.

6.

The influence of the BCL11A polymorphism on the phenotype of patients with beta thalassemia could be affected by the beta globin locus control region and/or the Xmn1-HBG2 genotypic background.

Neishabury M, Zamani F, Keyhani E, Azarkeivan A, Abedini SS, Eslami MS, Kakroodi ST, Vesiehsari MJ, Najmabadi H.

Blood Cells Mol Dis. 2013 Aug;51(2):80-4. doi: 10.1016/j.bcmd.2013.02.007. Epub 2013 Mar 28.

PMID:
23541515
7.

Prevalence of HER-2-positive invasive breast cancer: a systematic review from Iran.

Keyhani E, Muhammadnejad A, Karimlou M.

Asian Pac J Cancer Prev. 2012;13(11):5477-82. Review.

8.

Overexpression of her-2/neu in malignant mammary tumors; translation of clinicopathological features from dog to human.

Muhammadnejad A, Keyhani E, Mortazavi P, Behjati F, Haghdoost IS.

Asian Pac J Cancer Prev. 2012;13(12):6415-21.

Supplemental Content

Loading ...
Support Center